Cardiologs Holter Platform vs AVIEW Lung Nodule CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardiologs Holter Platform

by Philips France Commercial

AVIEW Lung Nodule CAD

by Coreline Soft Co.

AI Verdict

Tool A is designed for the analysis of Holter ECGs to detect cardiac arrhythmias, streamlining diagnostics for electrophysiology. In contrast, Tool B focuses on assisting radiologists with CT scan analysis for pulmonary nodule detection, lung cancer screening, and also includes coronary artery calcification scoring. While both utilize AI in cardiology, their primary diagnostic modalities and specific clinical applications are distinct.

Choose Cardiologs Holter Platform if…

Choose Cardiologs Holter Platform if your cardiology practice or hospital aims to significantly accelerate and improve the accuracy of Holter ECG analysis for arrhythmia detection. This cloud-based, AI-powered solution is ideal for organizations seeking vendor-neutral compatibility with existing Holter devices and seamless EMR integration to streamline cardiac diagnostic workflows and reduce analysis time.

View Cardiologs Holter Platform →

Choose AVIEW Lung Nodule CAD if…

Choose AVIEW Lung Nodule CAD if your radiology or pulmonology department requires an advanced AI solution for comprehensive chest CT scan analysis beyond just nodule detection. This tool is particularly well-suited for facilities focused on lung cancer screening, quantitative emphysema analysis, and coronary artery calcification scoring, offering detailed nodule tracking, classification, and multi-disease assessment for enhanced diagnostic capabilities.

View AVIEW Lung Nodule CAD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardiologs Holter Platform	AVIEW Lung Nodule CAD
Pricing	Contact sales	Contact for pricing
Deployment	Cloud-based (SaaS)	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiologs Holter Platform

Tool A emphasizes user efficiency by claiming a 42% reduction in Holter analysis time and generating easy-to-read, automatically enriched reports. Its cloud-based, vendor-neutral platform also offers anytime, anywhere access and compatibility with multiple Holter devices, streamlining workflow for healthcare professionals.

Clinical Value

AVIEW Lung Nodule CAD

While Tool A provides valuable arrhythmia detection, Tool B offers a broader and more comprehensive clinical assessment by simultaneously analyzing lung nodules, emphysema, and coronary artery calcification from a single CT scan. This 'Big 3' analysis provides integrated insights for lung cancer, COPD, and cardiovascular disease screening.

Pricing & Value

Cardiologs Holter Platform

Tool A offers a more transparent pricing model by explicitly stating 'Pay per ECG regardless the number of users,' which allows potential customers to better estimate costs based on their volume. Tool B's pricing is not publicly disclosed, with only general mentions of per-case fees or one-time investments.

Enterprise Readiness

Cardiologs Holter Platform

Tool A demonstrates strong enterprise readiness with explicit mentions of HIPAA compliance, FDA clearance, a Business Associate Agreement (BAA), and secure data hosting on ISO/IEC 27001 certified AWS servers. It also integrates with EMR systems via Philips IntelliBridge Enterprise. While Tool B offers flexible deployment options, Tool A's detailed security and integration assurances are critical for enterprise adoption.

Innovation

AVIEW Lung Nodule CAD

Both tools leverage AI, but Tool B's simultaneous analysis of lung nodules, emphysema, and coronary artery calcification (the 'Big 3') from a single CT scan represents a significant innovation in comprehensive diagnostic screening. This multi-disease detection capability offers a more holistic view of patient health compared to Tool A's focused arrhythmia detection.

Support & Docs

Cardiologs Holter Platform

Tool A explicitly provides information on how to access technical support through its platform's 'Help' menu and offers readily available documentation like brochures and white papers. Tool B's public information primarily references scientific articles and directs users to sales representatives for integration queries, lacking clear end-user support channels or general documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardiologs Holter Platform	AVIEW Lung Nodule CAD
Name	Cardiologs Holter Platform	AVIEW Lung Nodule CAD
Company	Philips France Commercial	Coreline Soft Co.
Primary Application	AI-powered, cloud-based solution for fast and accurate Holter ECG analysis, designed to detect over 20 types of arrhythmias and streamline cardiac diagnostics for healthcare professionals.	AI-powered software that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification.
Key AI Detections/Analysis	Detects over 20 types of arrhythmias; reduces Holter analysis time by approximately 42%.	AI-based pulmonary nodule detection (3-20 mm) on CT scans, nodule classification, 3D nodule size and volume quantification, automatic report generation based on Lung-RADS classification, nodule matching and volume doubling time (VDT) calculation, simultaneous analysis of lung nodules, emphysema, and coronary artery calcification (Big 3), quantitative emphysema analysis, Coronary Artery Calcification (CAC) scoring.
EMR Integration	Integration with Electronic Medical Record (EMR) systems (Philips IntelliBridge Enterprise)	Not specified

Videos

Demos, reviews, and walkthroughs featuring Cardiologs Holter Platform and AVIEW Lung Nodule CAD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into existing clinical workflows for cardiac diagnostics versus radiology interpretation?

The Cardiologs Holter Platform is designed to streamline Holter ECG analysis by providing AI-powered arrhythmia detection and automated reports, reducing analysis time by approximately 42%. AVIEW Lung Nodule CAD assists radiologists by automatically detecting and characterizing lung nodules on CT scans, generating Lung-RADS reports, and simultaneously analyzing emphysema and coronary artery calcification, acting as a second reader in the clinical radiology workflow.

What is the extent of EMR integration offered by each platform?

The Cardiologs Holter Platform integrates with Electronic Medical Record (EMR) systems, specifically mentioning Philips IntelliBridge Enterprise, to simplify cardiac diagnostic workflows. AVIEW Lung Nodule CAD generates automatic reports based on Lung-RADS classification and can integrate with PACS via DICOM, which facilitates documentation, though specific EMR integration details are not explicitly provided.

What specific accuracy or performance metrics are available for the AI detection capabilities of each tool?

The Cardiologs Holter Platform's AI has been shown to reduce false positive AF episodes by 10x while maintaining similar sensitivity, and increases sensitivity for VT detection by 29% (97% vs 68%). AVIEW Lung Nodule CAD has a reported sensitivity of 97% and specificity of 76% for pulmonary nodule detection at 1-FP/scan, and in aided radiologist performance, sensitivity improved from 68% to 91%.

Beyond the primary application, what additional clinical insights or specialties does each tool support?

The Cardiologs Holter Platform is specialized for cardiology, focusing on comprehensive Holter ECG analysis and detecting over 20 types of arrhythmias. AVIEW Lung Nodule CAD offers broader utility, assisting in radiology for lung nodule detection, pulmonology for quantitative emphysema analysis, and cardiology for coronary artery calcification (CAC) scoring, analyzing these 'Big 3' diseases simultaneously.

Do these tools provide features for tracking changes or maintaining an audit trail of analyses and reports?

The Cardiologs Holter Platform generates automatically enriched reports, which would capture the analysis output, and its cloud-based nature allows for multi-user access and collaboration. AVIEW Lung Nodule CAD offers automatic report generation based on Lung-RADS classification and includes nodule matching and volume doubling time (VDT) calculation for follow-up comparisons, which aids in tracking changes over time.

How quickly can a practice expect to see efficiency gains or integrate these tools into their daily operations?

The Cardiologs Holter Platform is designed to reduce Holter analysis time by approximately 42%, suggesting a rapid time-to-value through workflow optimization. AVIEW Lung Nodule CAD aims to advance radiology by assisting in detection and analysis, with studies suggesting it can drastically diminish radiologist workload by up to 86.7% in some screening scenarios, implying significant efficiency gains.